CBT
Price
$77.99
Change
+$0.77 (+1.00%)
Updated
May 2 closing price
Capitalization
5.11B
One day until earnings call
SCL
Price
$54.82
Change
+$1.39 (+2.60%)
Updated
May 2 closing price
Capitalization
1.99B
81 days until earnings call
Ad is loading...

CBT vs SCL

Header iconCBT vs SCL Comparison
Open Charts CBT vs SCLBanner chart's image
Cabot
Price$77.99
Change+$0.77 (+1.00%)
Volume$506.15K
Capitalization5.11B
Stepan
Price$54.82
Change+$1.39 (+2.60%)
Volume$243.54K
Capitalization1.99B
CBT vs SCL Comparison Chart
Loading...
CBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBT vs. SCL commentary
May 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBT is a Hold and SCL is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 04, 2025
Stock price -- (CBT: $77.99 vs. SCL: $54.82)
Brand notoriety: CBT and SCL are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: CBT: 111% vs. SCL: 158%
Market capitalization -- CBT: $5.11B vs. SCL: $1.99B
CBT [@Chemicals: Specialty] is valued at $5.11B. SCL’s [@Chemicals: Specialty] market capitalization is $1.99B. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $223.16B to $0. The average market capitalization across the [@Chemicals: Specialty] industry is $9.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBT’s FA Score shows that 2 FA rating(s) are green whileSCL’s FA Score has 0 green FA rating(s).

  • CBT’s FA Score: 2 green, 3 red.
  • SCL’s FA Score: 0 green, 5 red.
According to our system of comparison, CBT is a better buy in the long-term than SCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBT’s TA Score shows that 4 TA indicator(s) are bullish while SCL’s TA Score has 5 bullish TA indicator(s).

  • CBT’s TA Score: 4 bullish, 3 bearish.
  • SCL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CBT is a better buy in the short-term than SCL.

Price Growth

CBT (@Chemicals: Specialty) experienced а -1.53% price change this week, while SCL (@Chemicals: Specialty) price change was +13.64% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +1.77%. For the same industry, the average monthly price growth was -1.99%, and the average quarterly price growth was -8.24%.

Reported Earning Dates

CBT is expected to report earnings on Aug 11, 2025.

SCL is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Chemicals: Specialty (+1.77% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CBT($5.11B) has a higher market cap than SCL($1.99B). SCL has higher P/E ratio than CBT: SCL (50.52) vs CBT (12.08). CBT (-14.156) and SCL (-14.739) have similar YTD gains . CBT has higher annual earnings (EBITDA): 701M vs. SCL (170M). CBT has more cash in the bank: 244M vs. SCL (130M). SCL has less debt than CBT: SCL (712M) vs CBT (1.31B). CBT has higher revenues than SCL: CBT (3.92B) vs SCL (2.33B).
CBTSCLCBT / SCL
Capitalization5.11B1.99B257%
EBITDA701M170M412%
Gain YTD-14.156-14.73996%
P/E Ratio12.0850.5224%
Revenue3.92B2.33B169%
Total Cash244M130M188%
Total Debt1.31B712M184%
FUNDAMENTALS RATINGS
CBT vs SCL: Fundamental Ratings
CBT
SCL
OUTLOOK RATING
1..100
5259
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
30100
SMR RATING
1..100
3284
PRICE GROWTH RATING
1..100
7980
P/E GROWTH RATING
1..100
7096
SEASONALITY SCORE
1..100
35n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCL's Valuation (39) in the Chemicals Specialty industry is in the same range as CBT (47) in the Industrial Specialties industry. This means that SCL’s stock grew similarly to CBT’s over the last 12 months.

CBT's Profit vs Risk Rating (30) in the Industrial Specialties industry is significantly better than the same rating for SCL (100) in the Chemicals Specialty industry. This means that CBT’s stock grew significantly faster than SCL’s over the last 12 months.

CBT's SMR Rating (32) in the Industrial Specialties industry is somewhat better than the same rating for SCL (84) in the Chemicals Specialty industry. This means that CBT’s stock grew somewhat faster than SCL’s over the last 12 months.

CBT's Price Growth Rating (79) in the Industrial Specialties industry is in the same range as SCL (80) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to SCL’s over the last 12 months.

CBT's P/E Growth Rating (70) in the Industrial Specialties industry is in the same range as SCL (96) in the Chemicals Specialty industry. This means that CBT’s stock grew similarly to SCL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBTSCL
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
55%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
49%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
54%
Declines
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 6 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
CBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ROFCX10.250.27
+2.71%
Royce Small-Cap Opportunity Consult
LZUOX16.010.20
+1.27%
Lazard US Equity Focus Open
FFEIX13.48N/A
N/A
Nuveen Dividend Value A
MDVNX9.31N/A
N/A
MassMutual Diversified Value R3
PEYAX34.12N/A
N/A
Putnam Large Cap Value A

CBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBT has been closely correlated with WLK. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CBT jumps, then WLK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBT
1D Price
Change %
CBT100%
+1.00%
WLK - CBT
76%
Closely correlated
-13.46%
AVNT - CBT
76%
Closely correlated
+2.33%
OEC - CBT
69%
Closely correlated
+2.01%
IOSP - CBT
65%
Loosely correlated
+2.47%
SCL - CBT
64%
Loosely correlated
+2.60%
More

SCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCL has been closely correlated with AVNT. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCL jumps, then AVNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCL
1D Price
Change %
SCL100%
+2.60%
AVNT - SCL
77%
Closely correlated
+2.33%
KWR - SCL
75%
Closely correlated
-2.41%
IOSP - SCL
74%
Closely correlated
+2.47%
NGVT - SCL
70%
Closely correlated
+5.29%
OLN - SCL
67%
Closely correlated
+2.54%
More